Inhibition of tumour necrosis factor a converting enzyme as a new therapeutic target in inflammatory disease
No takes yet. Share an insight, caveat, or question.
Sander J. H. van Deventer (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: